# Pakistan export trends and trade challenges

> Developing situation record from CLSTR: https://clstr.news/situations/pakistan-export-trends-and-trade-challenges
> Updated: 2026-11-05T05:26:04.000Z. Sources: 2. Developments: 2.

Pakistan is facing various challenges affecting its export sectors. In the pharmaceutical industry, export values saw a significant downturn in fiscal year 2026, dropping from USD 457.456 million to USD 319.012 million. This decline is attributed to trade disruptions and border closures with Afghanistan, which has historically been a primary market for Pakistani medicines.

Separately, exports to Europe fell by 1.84 percent to $2.35 billion during the first quarter of fiscal year 2026-27. Beyond volume fluctuations, Pakistan faces potential risks regarding its Generalized Scheme of Preferences Plus (GSP+) status. Concerns regarding the human rights situation, including issues related to freedom of expression and enforced disappearances, may impact the country’s ability to maintain duty-free access to the European Union.

## Timeline

### 2026-11-05: Pakistan exports to Europe decline amid GSP+ status concerns

Pakistan’s exports to Europe declined by 1.84 percent in the first quarter of fiscal year 2026-27, while concerns grow over the potential loss of EU GSP+ duty-free status due to human rights issues.

2 sources. https://clstr.news/cluster/pakistan-exports-to-europe-decline-amid-gsp-status-concerns

### 2026-10-21: Pakistan pharmaceutical exports decline amid Afghan trade disruptions

Pakistan's pharmaceutical exports fell over 30% in FY26 and continued to decline in FY27, driven by trade disruptions and border closures with Afghanistan, a major market for the country's medicines.

4 sources. https://clstr.news/cluster/pakistan-afghanistan-trade-drops-by-74-percent

---
Cite as: Pakistan export trends and trade challenges. CLSTR, https://clstr.news/situations/pakistan-export-trends-and-trade-challenges